×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Jean Yu, CFA, Ph.D.

Jean Yu, CFA, Ph.D.

Managing Director, Portfolio Manager
24 Years experience
24 Years at firm

"Value can often be identified when alternative lenses are used to view a business."

Jean is a Portfolio Manager and member of the Global Value Equity investment team at ClearBridge Investments. She co-manages numerous U.S., global and international value strategies.  She joined the firm in 2002 and has 24 years of investment industry experience.

Jean began her tenure as a Research Analyst at Legg Mason Capital Management, covering the health care sector, as well as transportation logistical companies, industrial gas, and Chinese internet stocks and was then named Portfolio Manager. Legg Mason Capital Management integrated into ClearBridge in 2014.  Prior to joining the firm, she was a Senior Business Analyst managing consulting projects for Fortune 50 clients in the pharmaceutical industry at ISO Health Care Group.

Jean received a Ph.D. in molecular biology from Columbia University, an M.B.A. in health sector management and finance from Duke University, and an M.D. from Beijing Medical University. She is a CFA® charterholder.

Experience

  • 24 years of investment industry experience
  • Joined the firm in 2002
  • ISO Health Care Group – Senior Business Analyst
  • Ph.D. in molecular biology from Columbia University
  • M.B.A. in health sector management and finance from Duke University
  • M.D. from Beijing Medical University
  • CFA® charterholder

Perspectives

  • Crude Helped, Chips Hurt
    Value 3Q26: We are maintaining measured exposure to AI leaders while emphasizing diversification among attractively valued, durable businesses in overlooked sectors.
  • Bank Strength Meets an AI Air Pocket
    International Value 3Q26: Strong financials and energy exposure helped, but weakness in AI-exposed semiconductor and hardware holdings drove relative underperformance in a value-led international market.
  • Rebalancing After Momentum’s Reversal
    Global Value Improvers 3Q26: The Strategy trimmed industrials and added selectively to technology after July’s momentum selloff, as financials and materials helped but weakness in industrials, health care and communication services hurt.
MORE